| Data |
Ora |
Fonte |
Titolo |
|---|
| 08/1/2024 | 13:00 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
| 03/1/2024 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 27/12/2023 | 23:41 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:36 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 23:35 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27/12/2023 | 15:44 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 27/12/2023 | 15:43 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
| 27/12/2023 | 15:42 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
| 27/12/2023 | 14:54 | EDGAR2 | Form 8-K - Current report |
| 27/12/2023 | 14:31 | PRNUS | Lilly Completes Acquisition of POINT Biopharma |
| 18/12/2023 | 14:14 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 18/12/2023 | 13:30 | GLOBE | Lantheus and POINT Biopharma Announce Positive Topline.. |
| 18/12/2023 | 12:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 05/12/2023 | 12:25 | IHMARKETNEWS | Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio.. |
| 04/12/2023 | 13:22 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 04/12/2023 | 12:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 17/11/2023 | 13:05 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 17/11/2023 | 12:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
| 15/11/2023 | 13:00 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 14/11/2023 | 22:33 | PRNUS | Lilly Announces the Receipt of NRC Consent in Connection.. |
| 13/11/2023 | 13:30 | GLOBE | POINT Biopharma Reports Third Quarter 2023 Financial Results.. |
| 13/11/2023 | 13:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/11/2023 | 23:28 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 08/11/2023 | 22:56 | PRNUS | Lilly Announces Extension of Tender Offer to Acquire POINT.. |
| 08/11/2023 | 00:33 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 02/11/2023 | 23:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 01/11/2023 | 21:40 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 27/10/2023 | 22:20 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
| 13/10/2023 | 13:11 | EDGAR2 | Form SC 14D9 - Solicitation, recommendation statements |
| 03/10/2023 | 23:24 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 03/10/2023 | 16:03 | IHMARKETNEWS | Keep An Eye Out: Pre-Market Movers And Recommendations |
| 03/10/2023 | 13:37 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
| 03/10/2023 | 13:35 | EDGAR2 | Form 8-K - Current report |
| 03/10/2023 | 12:45 | PRNUS | Lilly to Acquire POINT Biopharma to Expand Oncology.. |
| 18/9/2023 | 14:00 | GLOBE | POINT Biopharma and Athebio Announce Partnership to Develop.. |
| 14/8/2023 | 16:22 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 14/8/2023 | 13:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14/8/2023 | 13:30 | GLOBE | POINT Biopharma Reports Second Quarter 2023 Financial.. |
| 14/8/2023 | 13:21 | EDGAR2 | Form 8-K - Current report |
| 03/8/2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 31/7/2023 | 15:00 | GLOBE | ITM and POINT Biopharma Expand Global Supply Agreement for.. |
| 26/6/2023 | 13:45 | GLOBE | POINT Biopharma and AdvanCell to Collaborate in the.. |
| 26/6/2023 | 13:30 | GLOBE | POINT Biopharma Expands Its Research with Next-Generation.. |
Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
